Chemomab Therapeutics (CMMB) Net Equity Issued and Repurchased (2018 - 2023)
Chemomab Therapeutics (CMMB) posted Net Equity Issued and Repurchased of $3000.0 for Q3 2023, down 99.99% on a QoQ basis from $45.4 million in Q1 2021.
Chemomab Therapeutics (CMMB) Net Equity Issued and Repurchased (2018 - 2023) Analysis & Trends
Chemomab Therapeutics' Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $3000.0 for Q3 2023.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $3000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $45.4 million (changed N/A YoY) and the FY2019 annual result came in at $30.5 million, up 33.19% from the prior year.
- Net Equity Issued and Repurchased was $3000.0 for Q3 2023 at Chemomab Therapeutics, down from $45.4 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $45.4 million in Q1 2021 and bottomed at $3000.0 in Q3 2023.
- A 3-year average of $25.3 million and a median of $30.5 million in 2019 frame the typical range for Net Equity Issued and Repurchased.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 141.90 Mn |
| 10 | Chemomab Therapeutics | 704.11 Mn | 693.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Mar 31, 2021 | 45.37 Mn |
| Mar 31, 2021 | 45.37 Mn |
| Mar 31, 2019 | 30.50 Mn |
| Mar 31, 2019 | 30.50 Mn |
| Dec 31, 2018 | 10.91 Mn |
| Dec 31, 2018 | 10.91 Mn |